CNN1y
Biohaven Ltd.
Biohaven Ltd. is a global clinical stage biopharmaceutical ... The company was founded on May 2, 2022 and is headquartered in New Haven, CT.
abc271mon
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
NEW HAVEN, Conn., Feb. 11, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the US Food and Drug Administration (FDA) has accepted for review the ...
Nature4y
Biohaven: committed to novel treatments for central nervous system diseases
These three therapeutic strategies could provide new approaches to a diverse set of unmet needs. Biohaven’s lead compounds are the CGRP receptor antagonist rimegepant and the glutamate modulator ...
PipelineReview.com10d
Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
NEW HAVEN, CT, USA I March 3, 2025 I Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, ...
Yahoo Finance1mon
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
Spinocerebellar Ataxia (SCA) is a rare, genetic, life-threatening neurodegenerative disease with no available treatment. Troriluzole demonstrated a 50-70% slowing of SCA disease progression on the ...